How Planning Councils/Planning Bodies Address Common Membership Issues in Their Bylaws
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 05/09/2024
Resource updated 02/02/2024
Resource updated 09/19/2023
Resource updated 01/05/2024
Resource updated 01/05/2024
Foundational information on a wide range of topics that planning council members need to know about.
Resource updated 12/15/2023
Resource updated 01/05/2024
Resource updated 01/16/2024
Resource updated 09/19/2023
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
TA and training on administration of Ryan White ADAPs and Part B planning and management. Project period: 2022-2027.
RWHAP Technical Assistance Provider updated on 04/15/2024
Implementation and evaluation of evidence-informed interventions to reduce HIV-related health disparities and improve health outcomes. Focus on transgender women, Black MSM, behavioral health integration, addressing trauma. TA provided to 26 RWHAP agencies. Project period: 2017-2022.
RWHAP Technical Assistance Provider updated on 03/04/2024
Review of how trauma-informed care services were implemented in a medical clinic and community organization, health department implementation actions, and client perspectives on these services.
Resource updated 11/07/2023
An evidence-based online curriculum for healthcare providers and trainers of health care providers on HIV/HCV co-infection among people of color.
Resource updated 09/19/2023
Resource updated 05/29/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024